- ISIN
- IL0011814113
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 29, 2024
Highlights
- Market Cap
- $12.60M
- Enterprise Value
- $11.30M
- EPS (TTM)
- -$2.56
- Gross Profit (TTM)
- -$459.00K
- EBITDA (TTM)
- -$4.45M
- Year Range
- $2.88 - $18.20
- ROA (TTM)
- -19.20%
- ROE (TTM)
- -19.60%
- Avg. Volume (1M)
- 59K
- Avg. Volume Value (1M)
- $804.92K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PLRZ Performance Chart
Polyrizon Ltd (PLRZ) is up 32.5% since the beginning of the year. At $11 per share, PLRZ is trading 38.2% below its 52-week high of $18.
Loading charts...
Compare this symbol against anything
Returns By Period
Polyrizon Ltd (PLRZ) has returned 32.51% so far this year and 72.02% over the past 12 months.
Polyrizon Ltd
- 1D
- -3.18%
- 1M
- -18.48%
- 6M
- -2.26%
- YTD
- 32.51%
- 1Y
- 72.02%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -95.38%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
PLRZ Monthly Returns History
Based on dividend-adjusted daily data since Oct 29, 2024, PLRZ's average daily return is +0.51%, while the average monthly return is +1.29%. At this rate, an investment would double in approximately 4.5 years.
Historically, 32% of months were positive and 68% were negative. The best month was Dec 2025 with a return of +164.5%, while the worst month was May 2025 at -98.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.
On a daily basis, PLRZ closed higher 41% of trading days. The best single day was May 2, 2025 with a return of +298.6%, while the worst single day was May 13, 2025 at -91.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 35.57% | 8.51% | -6.49% | 36.13% | 7.99% | -27.08% | -10.14% | 32.51% | |||||
| 2025 | -47.00% | -34.20% | -51.24% | -15.99% | -98.82% | -19.08% | 69.17% | -12.80% | -0.92% | -5.56% | -47.55% | 164.49% | -99.74% |
| 2024 | -15.85% | -32.03% | 131.34% | 32.32% |
Benchmark Metrics
Polyrizon Ltd has an annualized alpha of 235.61%, beta of 0.42, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 29, 2024.
- This stock participated in 42.97% of S&P 500 Index downside but only -174.04% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.42 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 235.61%
- Beta
- 0.42
- R²
- 0.00
- Upside Capture
- -174.04%
- Downside Capture
- 42.97%
Return for Risk
Risk / Return Rank
PLRZ ranks 71 for risk / return — above 71% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Polyrizon Ltd (PLRZ) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PLRZ | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.17 | ||
| Sortino ratioReturn per unit of downside risk | +0.62 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.25 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.86 | 2.00 | -1.14 |
| Martin ratioReturn relative to average drawdown | 2.32 | 8.49 | -6.18 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Polyrizon Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Polyrizon Ltd was 99.94%, occurring on Nov 26, 2025. The portfolio has not yet recovered.
The current Polyrizon Ltd drawdown is 99.77%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.94%Nov 2025 | 11mo 12d | — | 1y 7moDec 2024 - now | — |
-51.67%Nov 2024 | 15d | 1mo 3d | 1mo 18dOct 2024 - Dec 2024 | — |
-5.49%Oct 2024 | 1d | 1d | 1dOct 2024 - Oct 2024 | — |
Drawdown Indicators
| PLRZ | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.94% | -56.78% | -43.16% |
Max Drawdown (1Y)Largest decline over 1 year | -58.24% | -9.10% | -49.14% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.77% | -1.58% | -98.19% |
Average DrawdownAverage peak-to-trough decline | -88.28% | -10.70% | -77.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.06% | 2.14% | +19.92% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Polyrizon Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Polyrizon Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PLRZ in comparison with other companies in the Biotechnology industry. Currently, PLRZ has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PLRZ
Add Polyrizon Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PLRZ